ArticleBiomedicines2024

Effects of Once-Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction-Associated Steatotic Liver Disease in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real-World Data.

Hisayuki Katsuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.